Summary of included studies detailing sustained coverage outcomes beyond the initial timeframe of the intervention
| Study (target vaccination) | Baseline coverage | Postintervention coverage | Sustained coverage: timepoint 1 | Sustained coverage: timepoint 2 |
| Muehleisen et al (all due/overdue vaccinations)26 |
| Patients with ≥1 catch-up immunisation within 1 month:
| Patients with ≥1 catch-up immunisation within 9 months:
| – |
| Szilagyi et al (all due/overdue vaccinations)39 | 64% | Fully immunised for age at 1 day:
| Fully immunised for age at 6 months:
| – |
| Lemaitre et al (all upcoming neonatal vaccinations)71 | Not applicable (neonates) | Complete vaccine status at 3 months:
| Complete vaccine status at 13 months:
| Complete vaccine status at 24 months:
|
| Kushner et al (neonatal hepatitis B vaccination)59 | Not applicable (neonates) | Birth dose of hepatitis B vaccination=100% | Dose 2 (1–2 months)=81% | Dose 3 (6–18 months)=74% |
*Exact p value not provided.
ED, emergency department.